Teradyne, Inc.

NasdaqGS-TER

Basic

Market Cap
$19.41B
EV
$18.91B
Shares Out
156.11M
Revenue
$2,704.03M
Employees
6,200

Margins

Gross
57.06%
EBITDA
23.24%
Operating
19.01%
Pre-Tax
21.32%
Net
18.33%
FCF
17.7%

Returns (5Yr Avg)

ROA
20.4%
ROTA
34.28%
ROE
32.72%
ROCE
29.8%
ROIC
36.77%

Valuation (TTM)

P/E
—
P/B
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
EV/Gross Profit
—

Valuation (NTM)

Price Target
$147.46
P/E
—
PEG
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—

Financial Health

Cash
$460.56M
Net Debt
-$504.12M
Debt/Equity
0.03
EBIT/Interest
135.04

Growth (CAGR)

Rev 3Yr
-7.76%
Rev 5Yr
4.74%
Rev 10Yr
5.62%
Dil EPS 3Yr
-15.87%
Dil EPS 5Yr
3.25%
Dil EPS 10Yr
13.75%
Rev Fwd 2Yr
13.02%
EBITDA Fwd 2Yr
23.46%
EPS Fwd 2Yr
29.01%
EPS LT Growth Est
22.46%

Dividends

Yield
—
Payout
14.33%
DPS
$0.46
DPS Growth 3Yr
4.77%
DPS Growth 5Yr
5.02%
DPS Growth 10Yr
22.59%
DPS Growth Fwd 2Yr
7.27%

Metric	Dec '14	Dec '15	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	LTM
Total Revenues						2,295	3,121.5	3,702.9	3,155	2,676.3	2,704
Total Revenues % Chg.						9.2%	36%	18.6%	-14.8%	-15.2%	-5.5%
Cost of Goods Sold, Total						955.1	1,335.7	1,496.2	1,287.9	1,139.6	1,161.1
Gross Profit						1,339.8	1,785.7	2,206.7	1,867.2	1,536.7	1,543
Selling General & Admin Expenses, Total						446.4	476	546.6	536	582.6	589.3
R&D Expenses						322.8	375	427.6	440.6	418.1	421.6
Amortization of Goodwill and Intangible Assets						40.1	30.8	21.5	19.3	19	18.7
Other Operating Expenses						0.8	6.8	2.1	0.3	0.4	-0.6
Other Operating Expenses, Total						810.1	888.5	997.8	996.3	1,020.1	1,029
Operating Income						529.7	897.2	1,208.9	870.9	516.7	513.9
Interest Expense, Total						-22.2	-24.2	-17.8	-3.7	-3.8	-3.8
Interest And Investment Income						17	6	2.6	6.4	27.3	32.3
Net Interest Expenses						-5.2	-18.2	-15.2	2.7	23.5	28.5
Currency Exchange Gains (Loss)						-4.4	-6.1	-4.4	-8.3	-1.6	-11.4
Other Non Operating Income (Expenses)						4.9	0.3	1.3	1.9	0.3	0.3
EBT, Excl. Unusual Items						525	873.2	1,190.6	867.2	538.9	531.4
Restructuring Charges						-2.1	-1.6	—	-2.9	-14.7	-11.6
Merger & Related Restructuring Charges			—	—		-2.5	-1.7	-0.5	—	-3.6	-5.8
Impairment of Goodwill		—		—	—	—	—	—	—	—	—
Gain (Loss) On Sale Of Investments	—		—	—		-13.9	7.9	6.4	-9.9	7.5	7.5
Gain (Loss) On Sale Of Assets	—	—	—	—	—	—	—	—	3.4	—	57.5
Asset Writedown	—	—			—	—	—	—	—	—	—
Insurance Settlements	—	—			—	—	—	—	—	—	—
Legal Settlements	—	—	—	—	—	—	—	-12	-14.7	—	—
Other Unusual Items						19.2	23.3	-23.6	-2.7	-2.6	-2.6
EBT, Incl. Unusual Items						525.8	901	1,161	840.4	525.6	576.4
Income Tax Expense						58.3	116.9	146.4	124.9	76.8	80.8
Earnings From Continuing Operations						467.5	784.1	1,014.6	715.5	448.8	495.6
Net Income						467.5	784.1	1,014.6	715.5	448.8	495.6
Net Income to Common Incl Extra Items						467.5	784.1	1,014.6	715.5	448.8	495.6
Net Income to Common Excl. Extra Items						467.5	784.1	1,014.6	715.5	448.8	495.6
Total Shares Outstanding						166.6	166.1	162.3	155.8	152.7	157.8
Weighted Avg. Shares Outstanding						170.4	166.1	165	158.4	154.3	154.4
Weighted Avg. Shares Outstanding Dil						179.5	183	183.6	169.7	164.3	163
EPS						2.7	4.7	6.2	4.5	2.9	3.2
EPS Diluted						2.6	4.3	5.5	4.2	2.7	3
EBITDA						650.4	1,023.9	1,334.4	981.6	627.6	628.3
Effective Tax Rate						11.1%	13%	12.6%	14.9%	14.6%	14%